The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Purpura, Thrombocytopenic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Purpura, Thrombocytopenic


High impact information on Purpura, Thrombocytopenic


Chemical compound and disease context of Purpura, Thrombocytopenic


Biological context of Purpura, Thrombocytopenic


Anatomical context of Purpura, Thrombocytopenic


Gene context of Purpura, Thrombocytopenic


Analytical, diagnostic and therapeutic context of Purpura, Thrombocytopenic


  1. Sulfisoxazole-induced thrombocytopenic purpura. Immunologic mechanism as cause. Hamilton, H.E., Sheets, R.F. JAMA (1978) [Pubmed]
  2. Immune complexes as therapy for autoimmunity. Clynes, R. J. Clin. Invest. (2005) [Pubmed]
  3. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Oksenhendler, E., Bierling, P., Ferchal, F., Clauvel, J.P., Seligmann, M. Ann. Intern. Med. (1989) [Pubmed]
  4. Tissue uptake of circulating thrombopoietin is increased in immune-mediated compared with irradiated thrombocytopenic mice. Chang, M., Qian, J.X., Lee, S.M., Joubran, J., Fernandez, G., Nichols, J., Knoppel, A., Buzby, J.S. Blood (1999) [Pubmed]
  5. Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb). McMillan, R., Lopez-Dee, J., Loftus, J.C. Blood (2001) [Pubmed]
  6. Successful treatment of amegakaryocytic thrombocytopenic purpura with cyclosporine. Hill, W., Landgraf, R. N. Engl. J. Med. (1985) [Pubmed]
  7. Chronic immune thrombocytopenic purpura in monozygotic twins: genetic factors predisposing to ITP. Laster, A.J., Conley, C.L., Kickler, T.S., Dorsch, C.A., Bias, W.B. N. Engl. J. Med. (1982) [Pubmed]
  8. Thrombocytopenic purpura following iopanoic acid ingestion. Hysell, J.K., Hysell, J.W., Gray, J.M. JAMA (1977) [Pubmed]
  9. Oxytetracycline-induced thrombocytopenic purpura. Kounis, N.G. JAMA (1975) [Pubmed]
  10. Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia. Hosseinzadeh, P.K., Firkin, B.G., Pfueller, S.L. J. Clin. Invest. (1980) [Pubmed]
  11. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Blanchette, V., Imbach, P., Andrew, M., Adams, M., McMillan, J., Wang, E., Milner, R., Ali, K., Barnard, D., Bernstein, M. Lancet (1994) [Pubmed]
  12. Thrombocytopoietic effect of heparin given in chronic immune thrombocytopenic purpura. Shen, Z.X., Li, J.M., Wang, Z.Y., Han, Z.C., Caen, J.P., Bellucci, S.A. Lancet (1995) [Pubmed]
  13. Nafazatrom in thrombocytopenic purpura. Copplestone, J.A., Worsley, A., Sadullah, S., Hamblin, T.J. Lancet (1986) [Pubmed]
  14. Ribavirin and immune thrombocytopenic purpura. Jaccard, A., Loustaud, V., Turlure, P., Rogez, S., Bordessoule, D. Lancet (1998) [Pubmed]
  15. Identification of autoantibodies specific for the neutrophil adhesion glycoproteins CD11b/CD18 in patients with autoimmune neutropenia. Hartman, K.R., Wright, D.G. Blood (1991) [Pubmed]
  16. Platelet-associated CD154 in immune thrombocytopenic purpura. Solanilla, A., Pasquet, J.M., Viallard, J.F., Contin, C., Grosset, C., Déchanet-Merville, J., Dupouy, M., Landry, M., Belloc, F., Nurden, P., Blanco, P., Moreau, J.F., Pellegrin, J.L., Nurden, A.T., Ripoche, J. Blood (2005) [Pubmed]
  17. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg, A., Mauger, D. Semin. Hematol. (1998) [Pubmed]
  18. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura. Hansen, R.J., Balthasar, J.P. J. Pharmacol. Exp. Ther. (2001) [Pubmed]
  19. Clinical significance of HLA-DR+, CD19+, CD10+ immature B-cell phenotype and CD34+ cell detection in bone marrow lymphocytes from children affected with immune thrombocytopenic purpura. Callea, V., Comis, M., Iaria, G., Sculli, G., Morabito, F., Lombardo, V.T. Haematologica (1997) [Pubmed]
  20. Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Shivdasani, R.A., Fielder, P., Keller, G.A., Orkin, S.H., de Sauvage, F.J. Blood (1997) [Pubmed]
  21. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Kuwana, M., Kaburaki, J., Kitasato, H., Kato, M., Kawai, S., Kawakami, Y., Ikeda, Y. Blood (2001) [Pubmed]
  22. Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy. Corbacioglu, S., Bux, J., König, A., Gabrilove, J.L., Welte, K., Bussel, J.B. J. Pediatr. (2000) [Pubmed]
  23. Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelial cells. Rodríguez-Calvillo, M., Gabari, I., Duarte, M., Mazzolini, G., Rifón, J., Rocha, E., Prieto, J., Melero, I. Exp. Hematol. (2001) [Pubmed]
  24. ADAMTS13 turns 3. Levy, G.G., Motto, D.G., Ginsburg, D. Blood (2005) [Pubmed]
  25. Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura. Wu, K.H., Peng, C.T., Li, T.C., Wan, L., Tsai, C.H., Lan, S.J., Chang, M.C., Tsai, F.J. Br. J. Haematol. (2005) [Pubmed]
  26. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura. Han, Z.C., Bellucci, S., Tenza, D., Caen, J.P. Br. J. Haematol. (1990) [Pubmed]
  27. Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Yoshimura, C., Nomura, S., Nagahama, M., Ozaki, Y., Kagawa, H., Fukuhara, S. Eur. J. Haematol. (2000) [Pubmed]
  28. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Cooper, N., Woloski, B.M., Fodero, E.M., Novoa, M., Leber, M., Beer, J.H., Bussel, J.B. Blood (2002) [Pubmed]
  29. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Bettaieb, A., Oksenhendler, E., Duedari, N., Bierling, P. Clin. Exp. Immunol. (1996) [Pubmed]
  30. Confirming or excluding the diagnosis of Wiskott-Aldrich syndrome in children with thrombocytopenia of an unknown etiology. Ariga, T., Nakajima, M., Yoshida, J., Yamato, K., Nagatoshi, Y., Yanai, F., Caviles, A.P., Nelson, D.L., Sakiyama, Y. J. Pediatr. Hematol. Oncol. (2004) [Pubmed]
  31. Strategies for improving the functionality of an affinity bioreactor. Wang, T., Yang, Z., Emregul, E., David, A., Balthasar, J.P., Liang, J., Yang, V.C. International journal of pharmaceutics. (2005) [Pubmed]
  32. Immune thrombocytopenia associated with hemorrhagic diathesis due to ibuprofen administration. Meyer, T., Herrmann, C., Wiegand, V., Mathias, B., Kiefel, V., Mueller-Eckhardt, C. The Clinical investigator. (1993) [Pubmed]
WikiGenes - Universities